Alpha Tau Medical Ltd. (DRTS) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Alpha Tau Medical Ltd. (DRTS) closed at USD 13.50 on 2026-10-14, a change of +221.4 % over the past year, with a market capitalization of USD 1.22B.

Alpha Tau Medical Ltd. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Alpha Tau Medical Ltd. key figures

Previous close

USD 13.50 (2026-10-14)

1-year change

+221.4 %

Market cap

USD 1.22B

Enterprise value

USD 1.13B

P/E ratio (trailing)

-12.65

P/E ratio (forward)

-24.62

EPS (trailing)

-1.04

EPS (forward)

-0.53

PEG ratio

n/a

Price to book

27.59

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

5.49

Employees

121

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Alpha Tau Medical Ltd. and compare it with other stocks.